Header

UZH-Logo

Maintenance Infos

Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know


Opitz, I; Bueno, R; Lim, E; Pass, H; Pastorino, U; Boeri, M; Rocco, G; ESTS Biology Club (2014). Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know. European Journal of Cardio-Thoracic Surgery, 46(4):602-606.

Abstract

Today, molecular-profile-directed therapy is a guiding principle of modern thoracic oncology. The knowledge of new biomolecular technology applied to the diagnosis, prognosis, and treatment of lung cancer and mesothelioma should be part of the 21st century thoracic surgeons' professional competence. The European Society of Thoracic Surgeons (ESTS) Biology Club aims at providing a comprehensive insight into the basic biology of the diseases we are treating. During the 2013 ESTS Annual Meeting, different experts of the field presented the current knowledge about diagnostic and prognostic biomarkers in malignant pleural mesothelioma including new perspectives as well as the role and potential application of microRNA and genomic sequencing for lung cancer, which are summarized in the present article

Abstract

Today, molecular-profile-directed therapy is a guiding principle of modern thoracic oncology. The knowledge of new biomolecular technology applied to the diagnosis, prognosis, and treatment of lung cancer and mesothelioma should be part of the 21st century thoracic surgeons' professional competence. The European Society of Thoracic Surgeons (ESTS) Biology Club aims at providing a comprehensive insight into the basic biology of the diseases we are treating. During the 2013 ESTS Annual Meeting, different experts of the field presented the current knowledge about diagnostic and prognostic biomarkers in malignant pleural mesothelioma including new perspectives as well as the role and potential application of microRNA and genomic sequencing for lung cancer, which are summarized in the present article

Statistics

Citations

Dimensions.ai Metrics
3 citations in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Downloads

28 downloads since deposited on 02 Nov 2018
8 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:National licences > 142-005
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Surgery
Health Sciences > Pulmonary and Respiratory Medicine
Health Sciences > Cardiology and Cardiovascular Medicine
Uncontrolled Keywords:Biomarker; Genomic sequencing; Lung cancer; Malignant pleural mesothelioma; microRNAs
Language:English
Date:1 October 2014
Deposited On:02 Nov 2018 15:21
Last Modified:15 Apr 2021 14:50
Publisher:Oxford University Press
ISSN:1010-7940
OA Status:Hybrid
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/ejcts/ezu048
PubMed ID:24623168

Download

Hybrid Open Access

Download PDF  'Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know'.
Preview
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 97kB
View at publisher